Quarterly ResultSep 11, 2026, 03:06 PM
Champions Oncology Reports Q2 Loss of $426K on $15.2M Revenue
AI Summary
Champions Oncology, Inc. filed its Form 10-Q for the quarterly period ended July 31, 2026. The company reported a net loss of $426,000, an improvement from the $466,000 net loss in the same period last year. Oncology revenue saw an increase to $15.23 million from $13.99 million year-over-year. Total assets and liabilities both increased significantly from the previous quarter. The company also reported a substantial rise in stock-based compensation expense.
Key Highlights
- Champions Oncology reported a net loss of $426,000 for the three months ended July 31, 2026, compared to a net loss of $466,000 in the prior year period.
- Oncology revenue increased to $15.23 million for the three months ended July 31, 2026, up from $13.99 million in the same period last year.
- Total assets grew to $33.29 million as of July 31, 2026, from $26.99 million as of April 30, 2026.
- Total liabilities increased to $28.83 million as of July 31, 2026, from $22.92 million as of April 30, 2026.
- Stock-based compensation expense was $766,000 for the three months ended July 31, 2026, up from $208,000 in the prior year period.
- The company had $4.36 million in cash and cash equivalents as of July 31, 2026.
Price Impact
More from CSBR